MED-EL Cochlear Implant Becomes First FDA-Approved Option for Children Seven Months and Older
MED-EL USA announced today that the U.S. Food and Drug Administration (FDA) has approved an expanded indication for MED-EL cochlear implants for children seven months and older with bilateral sensorineural hearing loss (SNHL). This makes MED-EL’s cochlear implant system the only FDA-approved option for infants this young, offering the potential for earlier access to sound and speech development.
Starkey and MED-EL Announce All-New DualSync Partnership to Advance Bluetooth Connectivity for Cochlear Implant Users
Driven by a shared commitment to advancing hearing health, global hearing technology leaders Starkey and MED-EL are bringing their exclusive collaboration to life. Introducing DualSync, a bimodal streaming partnership enabling Apple technology to seamlessly stream to compatible Starkey hearing aids and MED-EL cochlear implants.
MED-EL and Starkey Announce Collaboration to Develop New Bluetooth Experience
Global hearing implant leader MED-EL and leading hearing innovator in technology Starkey announced today a collaboration that will enable an all-new Bluetooth listening experience for people with a MED-EL cochlear implant (CI) and Starkey products. The announcement was made at CI2024, the 17th International Conference on Cochlear Implants and Other Implantable Technologies, in Vancouver.
MED-EL Collaborates With Microsoft to Develop New Accessible Communication Technology for People With Hearing Loss
Hearing loss is on the rise, with the World Health Organization (WHO) estimating that 1 in 5 people already live with hearing loss. Many face daily challenges in communicating, from talking to friends, family, teachers, and colleagues to enjoying entertainment like watching their favorite TV show or listening to music. Today, two global technology leaders have joined forces to help connect people with hearing loss to the world around them.
